MyFinsight
Home
Blog
About
Back
Income Statement
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)
source: myfinsight.com
Comprehensive loss
-$42,220K
(-16.06%↓ Y/Y)
Net loss
-$41,492K
(-14.13%↓ Y/Y)
Unrealized gain on
investments
-$728K
(-3209.09%↓ Y/Y)
Other income, net
$3,804K
(40.42%↑ Y/Y)
Loss from operations
-$45,296K
(-15.95%↓ Y/Y)
Total operating
expenses
$45,296K
(15.95%↑ Y/Y)
Research and development
$36,296K
(18.81%↑ Y/Y)
General and
administrative
$9,000K
(5.70%↑ Y/Y)
Back